Vertex Pharmaceuticals (NASDAQ:VRTX) Given Reiterates Rating

888 reaffirmed their reiterates rating on shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) in a research report released on Monday, Benzinga reports. Several other research analysts also recently issued reports on VRTX. Maxim Group boosted their price objective on shares of Vertex Pharmaceuticals from $325.00 to $400.00 in a report on Wednesday, May 3rd. […]

Related Keywords

Bastiano Sanna , Stifel Nicolaus , Sanfordc Bernstein , Stuarta Arbuckle , Robertw Baird , News Ratings For Vertex Pharmaceuticals Daily , Vertex Pharmaceuticals , Advisory Group , Berkshire Asset Management , Proshare Advisors , Institutional Trading Of Vertex Pharmaceuticals , Maxim Group , Securities Exchange Commission , Old North State Trust , Analyst Recommendations For Vertex Pharmaceuticals , Vertex Pharmaceuticals Company Profile , Vertex Pharmaceuticals Stock , Vertex Pharmaceuticals Incorporated , Free Report , Moderate Buy , Exchange Commission , Asset Management , Teachers Pension Plan Board , Share Advisors , North State Trust , Pharmaceuticals Incorporated , Vertex Pharmaceuticals Daily ,